Pocket Program - CROI

Poster Listings
Session 197 CROI 2013
1095
Initiation: Rwandan Adults
Kathryn Anastos* 1 , Q Shi2 , JC Dusingize3 , E Mutimura3 , D Duggan4 ,
B Karenzi5 , I Izimukwiye6 , D Nash7 , D Smith4 , and D Hoover8 1Albert Einstein Coll of Med and Montefiore Med Ctr, Bronx, NY, US;;
2 3 Sch of Hlth Sci, New York Med Coll, Valhalla, US;; Womens Equity in
Access to Care and Treatment, Kigali, Rwanda;; 4Stevens Inst of Tech,
Hoboken, NY, US;; 5Rwanda Military Hosp, Kigali;; 6Masaka District
Hosp Kigali, Rwanda;; 7CUNY Sch of Publ Hlth Hunter Coll, NY, US;;
and 8Rutgers, the State Univ of New Jersey, New Brunswick, US
1096
South Africa
Ingrid Bassett* 1 , S Regan1 , H Mbonambi2 , J Blossom3 , S Bogan3 ,
R Walensky1,4 , B Mhlongo2 , H Thulare2 , K Freedberg1 , and E Losina1,4 1 2 Massachusetts Gen Hosp, Boston, US;; Ithembalabantu Peoples Hope
Clin/AIDS Hlthcare Fndn, Durban, South Africa;; 3Harvard Univ Ctr for
Geographic Analysis, Cambridge, MA, US;; and 4Brigham and Womens
Hosp, Boston, MA, US
1097
Ingrid Bassett* 1,2 , D Govindasamy3 , A Erlwanger1 , E Hyle1 , N van Schaik3 ,
F Noubary1 , R Wood3 , E Losina1,4,5 , L-G Bekker3 , and K Freedberg1,2,6 1 2 Massachusetts Gen Hosp, Boston, US;; Harvard Univ Ctr for AIDS
Res, Boston, MA, US;; 3Univ of Cape Town, South Africa;; 4Brigham and
Womens Hosp, Boston, MA, US;; 5Boston Univ Sch of Publ Hlth, MA, US;;
and 6Harvard Sch of Publ Hlth, Boston, MA, US
1098
Treatment Outcomes amongst HIV +
South Africa
Alana Brennan* 1,2 , M Maskew2 , I Sanne2,3,4 , and M Fox1,2,5 1 2 Ctr for Global Hlth and Devt, Boston Univ, MA, US;; Hlth Economics
and Epidemiology Res Office, Dept of Internal Med, Sch of Clin Med,
Faculty of Hlth Sci, Univ of the Witwatersrand, Johannesburg, South
Africa;; 3Right to Care, Johannesburg, South Africa;; 4Clin HIV Res Unit,
Dept of Internal Med, Sch of Clin Med, Faculty of Hlth Sci, Univ of the
Witwatersrand, Johannesburg, South Africa;; and 5Boston Univ Sch of
Publ Hlth, MA, US
1099
Insecurity and HIV Treatment Outcomes: Rural Uganda
Sheri Weiser* 1,2 , K Palar3 , E Frongillo4 , A Tsai5 , E Kumbakumba6 ,
N Grede7 , P Hunt1,2 , K Ragland1,2 , J Martin2 , and D Bangsberg5,6,8 1 2 San Francisco Gen Hosp, CA, US;; Univ of California, San Francisco,
US;; 3Univ of California, Los Angeles, US;; 4Arnold Sch of Publ Hlth,
Univ of South Carolina, Columbia, US;; 5Massachusetts Gen Hosp Ctr
for Global Hlth, Boston, US;; 6 1104 Retention in Care up to ART Initiation within a Decentralized
Clinic Visit
Melanie Plazy*
Mbarara Univ of Sci and Tech, Uganda;;
7 8 United Nations World Food Prgm, Rome, Italy;; and Ragon Inst of MGH,
MIT, and Harvard, Boston, MA, US
1,2 , R Dray-Spira3 , J Orne-Gliemann1,2 , F Dabis1,2 ,
and M-L Newell4 1 2 Univ Bordeaux, ISPED, INSERM U897, France;; ISPED, INSERM
U897, Bordeaux, France;; 3Epidemiology of Occupational and Social
Determinants of Hlth-Ctr for Res in Epidemiology and Population
Hlth, INSERM U1018, Villejuif, France;; and 4Africa Ctr for Hlth and
Population Studies, Univ of KwaZulu-Natal, South Africa
1105 Co-enrollment of HIV +
with Improved Outcomes for Women on ART: A Cohort Study
Landon Myer* 1 , J Duong2 , Y Zhang2 , E Abrams3 , R Carter3 ,
and MTCT-Plus Initiative
1 2 Univ of Cape Town, South Africa;; Mailman Sch of Publ Hlth, Columbia
Univ, New York, US;; and 3Intl Ctr for AIDS Care and Treatment Prgms,
Mailman Sch of Publ Hlth, Columbia Univ, New York, NY, US
1106
Barriers to Retention among HIV + Patients on ART: East
Africa
Elvin Geng* 1 , T Odeny2 , L Rita3 , A Nakiwogga-Muwanga4 , M Bwana5 ,
E Bukusi6 , G Somi3 , P Braitstein7 , C Yiannoutsos7 , J Martin1 ,
and East Africa Intl Epidemiologic Databases to Evaluate AIDS
1 2 Univ of California, San Francisco, US;; Family AIDS Care and Ed Svcs,
Kisumu, Kenya;; 3Natl AIDS Control Prgm, Dar es Salaam, Tanzania;;
4 5 Infectious Disease Inst, Kampala, Uganda;; Mbarara Univ of Sci
and Tech, Uganda;; 6Kenya Med Res Inst, Nairobi;; and 7Indiana Univ,
Indianapolis, US
1107 Real-time HIV ART Adherence Monitoring Predicts Loss
Uganda
Jessica Haberer* 1,2 , C Muzoora3 , P Hunt4 , J Martin4 , M Siedner1,2 ,
and D Bangsberg1,2,3 1 2 Massachusetts Gen Hosp, Boston, US;; Harvard Med Sch, Boston, MA,
US;; 3Mbarara Univ of Sci and Tech, Uganda;; and 4Univ of California,
San Francisco, US
c Wednesday, 2:30-4 pm; Hall B2
Session 199–Poster Abstracts
Virologic Failure, 2nd- and 3rd-line Therapy in RLS
st 1108
-line
Vincent Marconi* 1,2,3 , B Johnson2 , J Hampton4 , B Wu2 , M Gordon5,6 ,
S John4 , C Ordonez4 , R Murphy7 , D Kuritzkes8,9 , H Sunpath4 , and
South Africa Resistance Cohort Study
1 2 Emory Univ Sch of Med, Atlanta, GA, US;; Emory Univ Rollins Sch of
Publ Hlth, Atlanta, GA, US;; 3Atlanta VAMC, GA, US;; 4McCord Hosp,
Durban, South Africa;; 5Doris Duke Med Res Inst, Durban, South Africa;;
6 7 Univ of KwaZulu-Natal, Durban, South Africa;; Albert Einstein Med Sch,
Bronx, NY, US;; 8 and 9Harvard Med Sch, Boston, MA, US
1100 Does ART Attenuate the Stigma of HIV? Evidence from a
Cohort Study in Rural Uganda
Alexander Tsai* 1 , D Bangsberg 1 , M Bwana 2 , J Haberer 1 , E Frongillo 3 ,
C Muzoora 2 , E Kumbakumba 2 , P Hunt 4 , J Martin 4 , and S Weiser 4
1 Massachusetts Gen Hosp, Boston, US;; 2 Mbarara Univ of Sci and Tech,
Uganda;; 3 Univ of South Carolina, Columbia, US;; and 4 Univ of California,
San Francisco, US
c Tuesday, 2:30-4 pm; Hall B2
Session 198–Poster Abstracts
(see Session 48 on Wednesday for corresponding Themed Discussion)
Adherence and Retention in RLS
1101 Validating Measures of Distance to HIV Clinic in Rural
Uganda and Its Impact on Clinic Attendance
Mark Siedner* 1 , A Lankowski 1 , A Tsai 1,2 , C Muzoora 3 , P Hunt 4 ,
J Martin 4 , J Haberer 1 , and D Bangsberg 1,5
1 Massachusetts Gen Hosp Ctr for Global Hlth, Boston, US;;
2 Massachusetts Gen Hosp, Boston, US;; 3 Mbarara Univ of Sci and Tech,
Uganda;; 4 Univ of California, San Francisco, US;; and 5 Ragon Inst of
MGH, MIT, and Harvard Med Sch, Boston, US
1102 Site and Program Determinants of Patient Retention in HIV
Care: Nigeria
Chinenye Ugoji* 1 , R Ake-Uzoigwe 1 , MY Ladele 1 , C Akolo 1 , G Mendy 1 ,
P Dakum 1 , M Charurat 2 , D Onotu 3 , O Nwanyanwu 3 , and W Blattner 2
1 Inst of Human Virology Nigeria, Abuja;; 2 Inst of Human Virology,
Univ of Maryland, Baltimore, US;; and 3 Ctr for Disease Control, Nigeria
1103 Attrition through Multiple Stages of HIV Care in South
Africa: A Challenge for Test-and-Treat
Matthew Fox* 1,2,3 and K Shearer 3
1 Ctr for Global Hlth and Devt, Boston Univ, MA, US;; 2 Boston Univ Sch of
Publ Hlth, MA, US;; and 3 Hlth Economics and Epidemiology Res Office,
Univ of the Witwatersrand, Johannesburg, South Africa
70 20th Conference on Retroviruses and Opportunistic Infections
+ nd 1109
-line
Vu Thao* 1 , V Quang2 , M Wolbers1 , N Anh1 , N Chinh2 , C Shikuma3 ,
J Day1 , J Farrar1 , S Dunstan1 , and T Le1,3 1 2 Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam;; Hosp for
Tropical Diseases, Ho Chi Minh City, Vietnam;; and 3Hawaii Ctr for
AIDS, Univ of Hawaii at Manoa, Honolulu, US
1110
Associated with Elevated Mortality among HIV + Patients
Treated in Africa
Maya Petersen* 1 , L Tran 1 , E Geng 2 , S Deeks 2 , S Reynolds 3 , A Kambugu 4 ,
R Wood 5 , D Bangsberg 6 , C Yiannoutsos 7 , and J Martin 2
1 Univ of California, Berkeley, US;; 2 Univ of California, San Francisco,
US;; 3 Rakai Hlth Sci Prgm, Entebbe, Uganda;; 4 Infectious Diseases Inst,
Makerere, Uganda;; 5 Univ of Cape Town, South Africa;; 6 Harvard Med
Sch, Boston, MA, US;; and 7 Indiana Univ Sch of Med, Indianapolis, US
1111
Strategies on Mortality in HIV + African Adults on ART
D Ford 1 , J Robins 2 , M Petersen 3 , D Gibb 1 , C Gilks 4 , P Mugyenyi 5 ,
H Grosskurth 6 , J Hakim 7 , A Babiker 1 , Sarah Walker* 1 , and DART Trial
Team
1 MRC Clin Trials Unit, London, UK;; 2 Harvard Sch of Publ Hlth, Harvard
Univ, Boston, MA, US;; 3 Univ of California, Berkeley, US;; 4 Imperial
Coll London, UK;; 5 Joint Clin Res Ctr, Kampala, Uganda;; 6 MRC/UVRI
Uganda Res Unit on AIDS, Entebbe;; and 7 Univ of Zimbabwe, Harare
1112
1 st -line NNRTI-containing ART in Resource-limited Settings:
Nagalingeswaran Kumarasamy* 1 , E Aga 2 , H Ribaudo 2 , C Wallis 3 ,
D Katzenstein 4 , W Stevens 5 , M Norton 6 , K Klingman 7 , and J Bartlett 8
1 YRG CARE Med Ctr, Chennai, India;; 2 Statistical Data Analysis Ctr,
Harvard Univ, Boston, MA, US;; 3 Lancet Labs, Johanesburg, South Africa;;
4 Stanford Univ, CA, US;; 5 Univ of the Witwatersrand, Johannesburg, South
Africa;; 6 Abbott, IL, US;; 7 DAIDS, NIAID, NIH, Bethesda, MD, US;; and
8 Duke Univ Med Ctr, NC, US